Annual Operating Expenses
$795.39 M
+$189.09 M+31.19%
December 31, 2024
Summary
- As of March 12, 2025, BBIO annual total operating expenses is $795.39 million, with the most recent change of +$189.09 million (+31.19%) on December 31, 2024.
- During the last 3 years, BBIO annual operating expenses has risen by +$152.16 million (+23.66%).
- BBIO annual operating expenses is now at all-time high.
Performance
BBIO Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$225.13 M
+$35.87 M+18.95%
December 31, 2024
Summary
- As of March 12, 2025, BBIO quarterly total operating expenses is $225.13 million, with the most recent change of +$35.87 million (+18.95%) on December 31, 2024.
- Over the past year, BBIO quarterly operating expenses has increased by +$35.87 million (+18.95%).
- BBIO quarterly operating expenses is now at all-time high.
Performance
BBIO Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
BBIO Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +31.2% | +18.9% |
| 3 y3 years | +23.7% | +18.9% |
| 5 y5 years | +161.4% | +18.9% |
BBIO Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +46.6% | at high | +83.4% |
| 5 y | 5-year | at high | +161.4% | at high | +143.5% |
| alltime | all time | at high | +1713.6% | at high | +547.3% |
BridgeBio Pharma Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $795.39 M(+31.2%) | $225.13 M(+19.0%) |
| Sep 2024 | - | $189.26 M(+8.6%) |
| Jun 2024 | - | $174.22 M(-15.7%) |
| Mar 2024 | - | $206.78 M(+16.3%) |
| Dec 2023 | $606.30 M(+11.7%) | $177.81 M(+10.5%) |
| Sep 2023 | - | $160.91 M(+12.0%) |
| Jun 2023 | - | $143.61 M(+15.8%) |
| Mar 2023 | - | $123.97 M(+1.0%) |
| Dec 2022 | $542.65 M(-15.6%) | $122.76 M(-0.8%) |
| Sep 2022 | - | $123.70 M(-14.6%) |
| Jun 2022 | - | $144.83 M(-4.3%) |
| Mar 2022 | - | $151.36 M(-14.5%) |
| Dec 2021 | $643.23 M | $176.95 M(+17.7%) |
| Sep 2021 | - | $150.39 M(+1.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2021 | - | $147.93 M(-11.9%) |
| Mar 2021 | - | $167.97 M(+31.6%) |
| Dec 2020 | $482.73 M(+58.6%) | $127.61 M(-0.4%) |
| Sep 2020 | - | $128.07 M(+2.8%) |
| Jun 2020 | - | $124.57 M(+21.5%) |
| Mar 2020 | - | $102.49 M(+10.8%) |
| Dec 2019 | $304.30 M(+65.7%) | $92.46 M(+17.4%) |
| Sep 2019 | - | $78.77 M(+13.6%) |
| Jun 2019 | - | $69.32 M(+8.7%) |
| Mar 2019 | - | $63.75 M(-2.8%) |
| Dec 2018 | $183.66 M(+318.8%) | $65.58 M(+58.2%) |
| Sep 2018 | - | $41.46 M(+19.2%) |
| Jun 2018 | - | $34.78 M(-16.9%) |
| Mar 2018 | - | $41.84 M |
| Dec 2017 | $43.86 M | - |
FAQ
- What is BridgeBio Pharma annual total operating expenses?
- What is the all time high annual operating expenses for BridgeBio Pharma?
- What is BridgeBio Pharma annual operating expenses year-on-year change?
- What is BridgeBio Pharma quarterly total operating expenses?
- What is the all time high quarterly operating expenses for BridgeBio Pharma?
- What is BridgeBio Pharma quarterly operating expenses year-on-year change?
What is BridgeBio Pharma annual total operating expenses?
The current annual operating expenses of BBIO is $795.39 M
What is the all time high annual operating expenses for BridgeBio Pharma?
BridgeBio Pharma all-time high annual total operating expenses is $795.39 M
What is BridgeBio Pharma annual operating expenses year-on-year change?
Over the past year, BBIO annual total operating expenses has changed by +$189.09 M (+31.19%)
What is BridgeBio Pharma quarterly total operating expenses?
The current quarterly operating expenses of BBIO is $225.13 M
What is the all time high quarterly operating expenses for BridgeBio Pharma?
BridgeBio Pharma all-time high quarterly total operating expenses is $225.13 M
What is BridgeBio Pharma quarterly operating expenses year-on-year change?
Over the past year, BBIO quarterly total operating expenses has changed by +$35.87 M (+18.95%)